These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15003512)
21. Factor XIa dimer in the activation of factor IX. Sinha D; Marcinkiewicz M; Lear JD; Walsh PN Biochemistry; 2005 Aug; 44(30):10416-22. PubMed ID: 16042419 [TBL] [Abstract][Full Text] [Related]
22. Temporal changes in factors associated with neutrophil elastase and coagulation in intensive care patients with a biphasic waveform and disseminated intravascular coagulation. Samis JA; Stewart KA; Toh CH; Day A; Downey C; Nesheim ME J Thromb Haemost; 2004 Sep; 2(9):1535-44. PubMed ID: 15333027 [TBL] [Abstract][Full Text] [Related]
23. Substrate-dependent modulation of the mechanism of factor XIa inhibition. Pedicord DL; Seiffert D; Blat Y Biochemistry; 2004 Sep; 43(37):11883-8. PubMed ID: 15362874 [TBL] [Abstract][Full Text] [Related]
24. Effect of alkaline and acid phosphatases on clotting: Evidence that alkaline phosphatase enhances activation of factor IX by SF, and that acid phosphatase enhances plasmatic anti-SF. Iatridis PG; Ferguson JH Thromb Diath Haemorrh; 1966 May; 15(3):365-80. PubMed ID: 5989024 [No Abstract] [Full Text] [Related]
25. Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B. Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Ljung RC Pathophysiol Haemost Thromb; 2006; 35(5):370-5. PubMed ID: 17230038 [TBL] [Abstract][Full Text] [Related]
26. Purification and partial characterization of human neutrophil elastase inhibitors from the marine snail Cenchritis muricatus (Mollusca). González Y; Tanaka AS; Hirata IY; del Rivero MA; Oliva ML; Araujo MS; Chávez MA Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):506-13. PubMed ID: 16546427 [TBL] [Abstract][Full Text] [Related]
27. Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity. Yan JB; Wang S; Huang WY; Xiao YP; Ren ZR; Huang SZ; Zeng YT Biochem Genet; 2006 Oct; 44(7-8):349-60. PubMed ID: 17028784 [TBL] [Abstract][Full Text] [Related]
28. CoagMDB: a database analysis of missense mutations within four conserved domains in five vitamin K-dependent coagulation serine proteases using a text-mining tool. Saunders RE; Perkins SJ Hum Mutat; 2008 Mar; 29(3):333-44. PubMed ID: 18058827 [TBL] [Abstract][Full Text] [Related]
29. An RNA aptamer that discriminates bovine factor IX from human factor IX. Gopinath SC; Balasundaresan D; Akitomi J; Mizuno H J Biochem; 2006 Nov; 140(5):667-76. PubMed ID: 17030508 [TBL] [Abstract][Full Text] [Related]
30. Modulation of glyceraldehyde 3 phosphate dehydrogenase activity and tyr-phosphorylation of Band 3 in human erythrocytes treated with ferriprotoporphyrin IX. Omodeo-Salè F; Cortelezzi L; Riva E; Vanzulli E; Taramelli D Biochem Pharmacol; 2007 Nov; 74(9):1383-9. PubMed ID: 17714694 [TBL] [Abstract][Full Text] [Related]
31. Characterization of peptides resulting from digestion of human skin elastin with elastase. Getie M; Schmelzer CE; Neubert RH Proteins; 2005 Nov; 61(3):649-57. PubMed ID: 16161116 [TBL] [Abstract][Full Text] [Related]
32. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769 [TBL] [Abstract][Full Text] [Related]
33. [The activity of blood coagulation factor IX (Christmas factor). Studies of the physiological fluctuation range]. Hesse P; Mey U; Böhm W Munch Med Wochenschr; 1967 Oct; 109(41):2114-7. PubMed ID: 5631694 [No Abstract] [Full Text] [Related]
34. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. Osterud B; Bouma BN; Griffin JH J Biol Chem; 1978 Sep; 253(17):5946-51. PubMed ID: 681330 [No Abstract] [Full Text] [Related]
35. Binding of Cerebratulus cytolysin A-III to human erythrocyte membranes. Blumenthal KM Biochim Biophys Acta; 1985 Jan; 812(1):127-32. PubMed ID: 3843929 [TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene. Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401 [TBL] [Abstract][Full Text] [Related]
37. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing. Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892 [TBL] [Abstract][Full Text] [Related]
38. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer. Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137 [TBL] [Abstract][Full Text] [Related]